This page shows the latest MINT news and features for those working in and with pharma, biotech and healthcare.
Along with fellow MINT bloc countries Mexico, Indonesia and Nigeria, Turkey is considered an attractive market for the pharma industry thanks to its increasingly affluent population and long-term growth potential,
As one of the new MINT block of emerging markets (along with Mexico, Indonesia and Nigeria), the country has attracted quite a lot of investment from pharma multinationals, keen to tap
The law calls for serialised codes in a 2D datamatrix format which will be printed on self-adhesive security labels supplied by the Brazilian mint.
Mundipharma International (MINT) and its independent associated companies are perhaps more like an investor with go-to-market capabilities than a traditional pharmaceutical company. ... MINT realised this and moved quickly to facilitate the acquisition
The potential economic benefit of maintaining a healthy workforce should be considered when valuing health technologies
It is just one way that the private sector makes a mint out of stupid NHS targets.î.
More from news
Approximately 1 fully matching, plus 7 partially matching documents found.
The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
What is MINT? An acronym he coined for the ‘frontier’ markets of Mexico, Indonesia, Nigeria and Turkey. ... In our latest article for Pharmaphorum’s Deep Dive magazine Rachel Howard and Sue Rees investigate what the opportunities may be for pharma
Published in eye for pharma 3 April by Marc Yates. Last year, I concluded my series of articles outlining the challenges and opportunities for pharma in the “MINT” countries, by stating ... Whilst the private sector represents the greatest
Earlier this year, O’Neill came out of retirement to generate buzz about ‘MINT’ – that’s Mexico, Indonesia, Nigeria and Turkey to the uninitiated – as the next generation ‘ones to watch’ ... We will continue to monitor the MINT market,
Turkey. Why Turkey? With a population of approximately 75 million, Turkey has the smallest population of all of the ‘MINT’ markets. ... As a result the greatest opportunities for pharma, within the MINT markets, at this stage often lie within the
From a healthcare perspective, Nigeria has some parallels with the other MINT markets of Mexico and Indonesia. ... Given the infrastructural, political and fiscal challenges, Nigeria’s potential may also take longer to realise, relative to the other
More from PMHub
Approximately 2 fully matching, plus 6 partially matching documents found.
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...